JOHN C. REED - EVP, Innovative Medicine, R&D at JOHNSON & JOHNSON

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Innovative Medicine, R&D
Issuer Symbol
JNJ on NYSE
All Insider Reports
All Insider Reports

JOHN C. REED - trading volume in the past year for JOHNSON & JOHNSON

Holdings reported by JOHN C. REED for JOHNSON & JOHNSON

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Options (Right to Buy) 43,442 $6,860,360 $157.92 17 Oct 2025 Direct Common Stock
Common Stock 10,658 $2,053,873 $192.71 17 Oct 2025 Direct
Restricted Share Units 25,255 $864,915 $156.15 01 May 2025 Direct Common Stock

Transactions reported by JOHN C. REED for JOHNSON & JOHNSON

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.